Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 1164-1175

  Chen, Wen Ji ^a   Armour, Susan ^a   Way, James ^a   Chen, Grace ^a   Watson, Chris ^a   Irving, Paul ^a   Cobb, Jeff ^a   Kadwell, Sue ^a   Beaumont, Kevin ^b   Rimele, Tom ^a   Kenakin, Terry ^a  

^a GLAXOSMITHKLINE   (United States)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; CALCITONIN RECEPTOR; COMPLEMENTARY DNA; IODINE 125; RECOMBINANT HORMONE; SALCATONIN; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN MCF 7; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT;

EID: 0031469952     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.1164     Document Type: Article

References (33)

1. Bretherton-Watt, D., and S. R. Bloom. Islet amyloid peptide: the cause of type-2 diabetes? Trends Endocrinol. Metab. 2:203-206 (1991).
2. Edwards, B. J.-A., and J. E. Morley. Minireview: amylin. Life Sci. 51:1899-1912 (1992).
3. Rink, T. J., K. Beaumont, J. Koda, and A. Young. Structure and function of amylin. Trends Pharmacol. Sci. 14:113-118 (1993).
4. Beaumont, K., M. A. Kenney, A. A. Young, and T. J. Rink. High affinity amylin binding in rat brain. Mol. Pharmacol. 44:493-497 (1993).
5. 125I]Bolton-Hunter rat amylin binding sites in the rat brain. J. Pharmacol. Exp. Ther. 270:779-787 (1994).
6. Veale, P. R., R. Bhogal, D. G. A. Morgan, D. M. Smith, and S. R. Bloom. The presence of islet amyloid polypeptide/calcitonin gene-related peptide/ salmon calcitonin binding sites in the rat nucleus accumbens. Eur. J. Pharmacol. 262:133-141 (1994).
7. Cooper, G. J. S., B. Leighton, A. C. Willis, and A. J. Day. The amylin superfamily: a novel grouping of biologically active polypeptides related to the insulin A-chain. Progr. Growth Factor Res. 1:99-105 (1989).
8. Cooper, G. J. S., A. J. Day, A. C. Willis, A. N. Roberts, K. B. M. Reid, and B. Leighton. Amylin and the amylin gene: structure, function, and relationship to islet amyloid and to diabetes mellitus. Biochim. Biophys. Acta 1014:247-258 (1989).
9. Watson, C. A., G. Chen, P. E. Irving, J. K. Cobb, K. Beaumont, K. S. Prickett, T. Rimele, and T. P. Kenakin. The pharmacology of amylin receptors in the rat nucleus accumbens: effects of receptor/G-protein interactions on ligand affinity (abstract). FASEB J. 9:A668 (1995).
10. Kuestner, R. E., R. D. Elrod, F. J. Grant, F. S. Hagen, J. L. Kuijper, S. L. Matthewes, P. J. O'Hara, P. O. Sheppard, S. D. Stroop, D. L. Thompson, T. E. Whitmore, D. M. Findlay, S. Houssami, P. M. Sexton, and E. E. Moore. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol. Pharmacol. 46:246-255 (1994).
11. Cheng, Y. C., and W. H. Prusoff. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition on an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
12. Sambrooke, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
13. Kaufmann, R. J., M. V. Davies, V. K. Pathak, and J. W. Hershey. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell Biol 9:946-58 (1989).
14. Luckow, V. A., S. C. Lee, G. F. Barry, and P. O. Olins. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 67:4566-4579 (1993).
15. Gorn, A. H., H. Y. Lin, M. Yamin, P. E. Auron, M. R. Flannery, D. R. Tapp, C. A. Manning, H. F. Lodish, S. M. Krane, and S. R. Goldring. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J. Clin. Invest. 90:1726-1735 (1992).
16. Egerton, M., M. Needham, S. Evans, A. Millest, G. Cerillo, J. McPheat, M. Popplewell, D. Johnsonte, and M. Hollis. Identification of multiple human calcitonin receptor isoforms: heterologous expression and pharmacological characterization. J. Mol. Endocrinol. 14:179-189 (1995).
17. Moore, E. E., R. E. Kuestner, S. D. Stroop, F. J. Grant, S. L. Matthewes, C. L. Brady, P. M. Sexton, and D. M. Findlay. Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol. Endocrinol. 9:959-968 (1995).
18. Albrandt, K., E. M. G. Brady, C. X. Moore, E. Mull, M. E. Sierzega, and K. Beaumont. Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. Endocrinology 136:5377-5384 (1995).
19. Nussenveig, D. H., C. N. Thaw, and M. C. Gershengorn. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. J. Biol. Chem. 269:28123-28129 (1994).
20. Neubig, R. R. Membrane organization in G-protein mechanisms. FASEB J. 8:939-946 (1994).
21. i proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age. J. Pharmacol. Exp. Ther. 269:1062-1072 (1994).
22. 2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities. Biochem. Pharmacol. 51:71-76 (1996).
23. De Lean, A., J. M. Stadel, and R. J. Lefkowitz. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:7108-7117 (1980).
24. 2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:4625-4636 (1993).
25. Weiss, J. M., P. H. Morgan, M. W. Lutz, and T. P. Kenakin. The cubic ternary complex receptor-occupancy model. I. Model description. J. Theoret. Biol. 178:151-167 (1996).
26. Weiss, J. M., P. H. Morgan, M. W. Lutz, and T. P. Kenakin. The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity. J. Theoret. Biol. 178:169-182 (1996).
27. Matesic, D. F., D. R. Manning, and G. R. Luthin. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins. Mol. Pharmacol. 40:347-353 (1991).
28. Kenakin, T. P. The nature of agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16:232-238 (1995).
29. Kenakin, T. P. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48:413-463 (1996).
30. Horne, W. C., J.-F. Shyu, M. Chakraborthy, and R. Baron. Signal transduction by calcitonin: multiple ligands, receptors, and signaling pathways. Trends Endocrinol. Metab. 5:395-401 (1994).
31. Chakraborthy, M., D. Chatterjee, S. Kellokumpu, H. Rasmussen, and R. Baron. Cell cycle-dependent coupling of the calcitonin receptor to different G-proteins. Science (Washington D. C.) 251:1078-1082 (1991).
32. 1 adenosine/G-protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G-protein complex. Mol. Pharmacol. 48:806-817 (1995).
33. Sato, M., R. Kataoka, J. Dingus, M. Wilcox, J. D. Hildebrandt, and S. M. Lanier. Factors determining specificity of signal transduction by G-protein coupled receptors. J. Biol. Chem. 270:15269-15276 (1995).